URL has been copied successfully!
Josh Kushner’s Thrive Capital and Alphabet (NASDAQ:GOOG) are leading new financing for Isomorphic Labs, an AI-powered drug discovery company.
The London-based company, spun out of Google DeepMind, plans to raise $2 billion to expand its business globally, Bloomberg reported.
Isomorphic, founded in 2021 by DeepMind co-founder Demis Hassabis, functions as a “digital biology” lab aimed at revolutionizing the pharmaceutical industry by designing novel medicines using machine learning.
data-variant=”card”
data-news-mode=”manual”
>
Read Also:
Brookfield Asset Management CEO Says AI Is A ‘Significant Tailwind’ Amid …
Please follow us:
This post was originally published here
